QCG
CLLS

Quadrant Capital Group’s Cellectis CLLS Stock Holding History

Quadrant Capital Group’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.99K Sell
944
-1,817
-66% -$6.96K ﹤0.01% 2450
2025
Q4 		$13.4K Buy
+2,761
New +$11.5K ﹤0.01% 2125
2022
Q2 		– Sell
-1,036
Closed -$5K – 2563
2022
Q1 		$5K Sell
1,036
-832
-45% -$4.58K ﹤0.01% 1896
2021
Q4 		$15K Buy
1,868
+926
+98% +$9.1K ﹤0.01% 1426
2021
Q3 		$12K Buy
942
+248
+36% +$3.44K ﹤0.01% 1479
2021
Q2 		$11K Buy
+694
New +$11.7K ﹤0.01% 1501
2020
Q1 		– Sell
-361
Closed -$6K – 2129
2019
Q4 		$6K Buy
+361
New +$4.82K ﹤0.01% 2033

Other funds holding CLLS

BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Quadrant Capital Group's CLLS Position: Q1 2026 in Review

Quadrant Capital Group reduced its Cellectis (CLLS) stake by 66% in Q1 2026, selling an estimated $6.96K and leaving 944 shares worth $2.99K. The position accounts for ﹤0.01% of the portfolio, ranked #2450.

Quadrant Capital Group first reported a position in CLLS in Q4 2019 and has held it in 7 quarters since. The position peaked at $15K in Q4 2021. 32 funds tracked by Wall St. Rank hold CLLS as of Q1 2026.

  • Quadrant Capital Group held 944 shares of Cellectis worth $2.99K as of Q1 2026.
  • Quadrant Capital Group sold 1,817 Cellectis shares in Q1 2026, an estimated $6.96K.
  • Cellectis made up ﹤0.01% of Quadrant Capital Group's portfolio in Q1 2026, its #2450 holding.
  • Quadrant Capital Group first reported a position in Cellectis in Q4 2019 and has held it in 7 quarters since.
  • Quadrant Capital Group's Cellectis position peaked at $15K in Q4 2021.
  • 32 funds tracked by Wall St. Rank held Cellectis as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.